4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...
News Medical58m
Machine learning reveals why cancer trials fall short in real-world patients
TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...